Location History:
- Lower Gwynedd, PA (US) (2020)
- Philadelphia, PA (US) (2016 - 2024)
Company Filing History:
Years Active: 2016-2024
Title: Vikram Bhattacharjee: Innovator at the Forefront of Cancer Research
Introduction
Vikram Bhattacharjee, based in Philadelphia, PA, is a prominent inventor known for his contributions to cancer research through innovative patents. With a total of eight patents to his name, he has made significant strides in understanding and treating cancer, particularly through the inhibition of thymine DNA glycosylase.
Latest Patents
Bhattacharjee's latest inventive work revolves around the inhibition of thymine DNA glycosylase in the treatment of cancer. His invention includes compositions, kits, and methods designed to induce growth arrest, differentiation, or senescence of cancer cells that express thymine DNA glycosylase. By inhibiting the expression or biological activity of thymine DNA glycosylase, his methods aim to revert cancer cells to a healthy, non-cancerous phenotype, or induce them to senesce. His research particularly targets various types of cancer, including melanoma, lung, prostate, pancreatic, ovarian, brain, colon, recto-sigmoid colon, and breast cancer cells.
Career Highlights
Throughout his career, Vikram has collaborated with several notable organizations, including the Institute for Cancer Research and Evol Science LLC. His work is highly regarded in the research community, thanks to his innovative approaches to cancer treatment and understanding.
Collaborations
In his professional journey, Bhattacharjee has worked alongside esteemed colleagues such as Timothy J. Yen and Alfonso Bellacosa. Their collective efforts in the field of cancer research amplify the impact of their contributions to medical science.
Conclusion
Vikram Bhattacharjee stands out as a significant figure in the realm of cancer research innovation. His groundbreaking patents highlight the potential for new cancer therapies and exemplify the important role inventors play in advancing medical science. With his continued research and collaboration, there is hope for new advancements in the fight against cancer.